PETMED EXPRESS INC PETS
PETMED EXPRESS INC financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $281.1M | $256.6M | $272.3M | $309.2M | $284.1M | $283.4M | $273.8M | $249.2M |
| Gross profit | $50.2M | $69.1M | $84.8M | $76.5M | $76.9M | $89.9M | $81.2M | $95.3M | $97.8M | $79.3M |
| Operating income | -$58.7M | -$1.5M | -$8.2M | $6.1M | $24.3M | $37.6M | $31.0M | $46.2M | $52.1M | $37.5M |
| Income tax | -$73,000 | $5.7M | $1.2M | $2.3M | $5.5M | $8.6M | $8.0M | $11.4M | $16.5M | $14.1M |
| Net income | -$57.3M | -$6.3M | -$7.5M | $5.1M | $18.7M | $30.6M | $25.9M | $37.7M | $37.3M | $23.8M |
| EPS (diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.52 | $1.29 | $1.84 | $1.82 | $1.17 |
| Operating cash flow | -$28.4M | $4.7M | $4.3M | $27.8M | $18.5M | $40.1M | $38.8M | $45.1M | $37.4M | $47.2M |
| Free cash flow | -$33.0M | -$395,000 | -$194,000 | $22.5M | $16.7M | $37.6M | $36.5M | $44.5M | $36.7M | $36.6M |
| Cash & equivalents | $21.4M | $54.7M | $55.3M | $104.1M | $111.1M | $118.7M | $103.8M | $100.5M | $77.9M | $58.7M |
| Inventory | $13.6M | $16.2M | $28.6M | — | — | — | — | — | — | — |
| Total assets | $81.2M | $148.7M | $169.9M | $167.5M | $176.3M | $187.5M | $155.3M | $154.4M | $134.8M | $112.8M |
| Total liabilities | $52.3M | $63.6M | $73.2M | $57.5M | $34.1M | $46.2M | $25.3M | $19.7M | $19.1M | $19.4M |
| Shareholders' equity | $28.9M | $85.1M | $96.7M | $110.0M | $123.5M | $124.9M | $130.0M | $134.7M | $115.7M | $93.4M |
Growth · year-over-year · Revenue CAGR -3.6%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -21.1% | -19.2% | +9.5% | -5.8% | -11.9% | +8.8% | +0.2% | +3.5% | +9.9% | +6.2% |
| Net income growth | — | — | -245.2% | -72.5% | -38.8% | +18.4% | -31.5% | +1.2% | +56.5% | +15.8% |
| EPS growth | — | — | -248.0% | -72.8% | -39.5% | +17.8% | -29.9% | +1.1% | +55.6% | +14.7% |
| Free cash flow growth | — | — | -100.9% | +34.6% | -55.5% | +3.0% | -17.9% | +21.4% | +0.2% | +3865.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.